Group photo of leaders, guests and representatives of member units

On July 26, the inaugural meeting of the Medical Device Professional Committee of the China International Import Expo Exhibitors Alliance (hereinafter referred to as the Special Committee) was held at the National Convention and Exhibition Center (Shanghai). This event was hosted by the China International Import Expo Bureau and was the fourth One of the 100-day countdown to the opening of the CIIE. The State Drug Administration, Shanghai Drug Administration, Shanghai Medical Security Bureau and other industry authorities and BD Medical, Medtronic, Johnson & Johnson, Abbott, GE Healthcare, Stryker, KaVo, Danaher, Siemens Healthcare, 43 member units including Boston Scientific, Immena, Canon Medical, BioMérieux, Roche Diagnostics, and Karl Storz participated in the event.

Licensing ceremony

The conference voted to pass the charter of the special committee, and held a licensing ceremony. BD Medical served as the first chairman unit, and four companies including Medtronic, Johnson & Johnson, Abbott, and GE Healthcare served as vice chairman units. The establishment of the special committee was aimed at To further leverage the functions of the CIIE platform and promote resource gathering, 43 start-up member units brought together leaders in various subdivisions of medical devices such as in vitro diagnostics, high-value consumables, cardiovascular, medical imaging, orthopedics, oral cavity, genetic testing, etc. Among them, the world 10 Fortune 500 companies; promote political and business exchanges, invite Shanghai Drug Administration as the support unit of the special committee to guide the work; promote industrial innovation, plan to release the research results of special committees such as the "Medical Device Industry White Paper" to help industrial innovation Upgrade; promote open cooperation, member units will join hands to create high-standard industry events during the 4th CIIE, share industry experience, and explore the future of the industry.

Speech by Liu Fuxue, Deputy Director of China International Import Expo Bureau

Liu Fuxue, deputy director of the China International Import Expo Bureau, said at the event that the 4th CIIE will further enhance the professionalism of exhibitions, innovate work measures, and strengthen the construction of exhibitor alliances and special committees. The establishment of the medical device professional committee this time is The CIIE conforms to the people's yearning for a better life and serves the important measures of the national strategic deployment. It is hoped that the members of the special committee will give full play to their leading and exemplary roles, offer suggestions, pioneer and innovate on the CIIE platform, and contribute to the development of the medical device industry.

The Department of Science and Technology and Cooperation of the State Drug Administration stated at the event that China’s demand for high-quality medical devices will continue to grow, and the State Drug Administration will actively create a more scientific and open medical device market access and regulatory policy environment, and welcome excellence Of companies have brought their best products to the Chinese market through the CIIE platform to better serve the health of the people; the Device Supervision Department of the State Drug Administration has made a policy interpretation on the newly revised "Regulations on the Supervision and Administration of Medical Devices" to help companies improve Good understanding of relevant regulatory measures to achieve higher quality, more efficient and safer development.

Deng Jianmin, Global Senior Vice President and General Manager of Greater China Region of BD Medical, read out the proposal

Deng Jianmin, global senior vice president and general manager of Greater China of BD Medical, the chairman unit, said at the event that the establishment of a medical device committee at the CIIE is of great significance. BD Medical will make full use of this platform to connect all parties and provide better services. In the Chinese market, it is recommended that all member units give full play to their own advantages, actively participate in the work of the special committee, seek opportunities in the open market, and work together for a win-win situation.

Chen Jianzhong, Global Vice President of Abbott Diagnostics, delivered a speech

Chen Jianzhong, vice president unit representative of Abbott Diagnostics, said at the event that the strong spillover effect of the CIIE has allowed Abbott to enjoy more development opportunities. Abbott will use the platform of the special committee to work with industry partners to help the medical device industry. Development and innovation will introduce more cutting-edge technologies and innovations into China.

Meeting scene